Publication | Open Access

Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

Treatment And PreventionPharmacologyAntiviral Drug DevelopmentAntiviral TherapyPharmacotherapyTail-phase SafetyAntiviral DrugHivHptn 077MedicineLong-acting Injectable Cabotegravir